Current and future status of extracorporeal life support for respiratory failure in adults

Current Opinion in Critical Care

Volumn 22, Issue 1, 2016, Pages 80-85

  Bartlett, Robert H ^a   Deatrick, Kristopher B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acute respiratory distress syndrome; Artificial lung; Extracorporeal membrane oxygenation

Indexed keywords

CARBON DIOXIDE;

ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ALGORITHM; AMBULATORY CARE; ANTICOAGULATION; BREATHING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; HUMAN; LUNG TRANSPLANTATION; PATIENT CARE; REVIEW; SURVIVAL RATE; WAKEFULNESS; ACUTE DISEASE; ADULT; ARTIFICIAL VENTILATION; CAUSE OF DEATH; DISEASE COURSE; FEMALE; INTENSIVE CARE; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY INSUFFICIENCY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; CAUSE OF DEATH; CRITICAL CARE; DISEASE PROGRESSION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84952684258     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000274     Document Type: Review

References (24)

1. Fortenberry J. The history and development of extracorporeal support. In: Annich GM, MacLaren G, Wilson JM, et al., editors. ECMO: extracorporeal cardiopulmonary support in critical care, 4th ed. United States: Extracorporeal Life Support Organization; 2012. pp. 1-10.
2. Paden ML, Conrad SA, Rycus PT, et al. Extracorporeal Life Support Organization Registry Report. ASAIO J 2013; 59: 202-210.
3. Jegger D, Revelly JP, Horisberger J, et al. Ex vivo evaluation of a new extracorporeal lung assist device: NovaLung membrane oxygenator. Int J Artif Organs 2005; 28: 985-999.
4. Zhou X, Loran DB, Wang D, et al. Seventy-two hour gas exchange performance and hemodynamic properties of NOVALUNG iLA as a gas exchanger for arteriovenous carbon dioxide removal. Perfusion 2005; 20: 303-308.
5. Naso F, Gandaglia A, Balboni P, et al. Wet-priming extracorporeal membrane oxygenation device maintains sterility for up to 35 days of follow-up. Perfusion 2013; 28: 208-213.
6. Wiktor AJ, Haft JW, Bartlett RH, et al. Prolonged VV ECMO (265 days) for ARDS without technical complications. ASAIO J 2015; 61: 205-206.
7. Rosenberg AA, Haft JW, Bartlett R, et al. Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation? ASAIO J 2013; 59: 642-650.
8. HoopesCW, Kukreja J, Golden J, et al. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg 2013; 145: 862-867.
9. Bartlett RH. Physiology of extracorporeal life support. ECMO: extracorporeal support in critical care. Ann Arbor, MI: Extracorporeal Life Support Organization; 2012; 11-31.
10. Kolobow T. An update on adult extracorporeal membrane oxygenation-extracorporeal CO2 removal. ASAIO Trans 1988; 34: 1004-1005.
11. Gattinoni L, Agostoni A, Pesenti A, et al. Treatment of acute respiratory failure with low-frequency positive-pressure ventilation and extracorporeal removal of CO2. Lancet 1980; 2: 292-294.
12. Gattinoni L, Pesenti A, Mascheroni D, et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 1986; 256: 881-886.
13. Chiumello D, Coppola S, Froio S, et al. Extracorporeal life support as bridge to lung transplantation: a systematic review. Critical Care 2015; 19: 19.
14. Lehr CJ, Zaas DW, Cheifetz IM, Turner DA. Ambulatory extracorporeal membrane oxygenation as a bridge to lung transplantation: walking while waiting. Chest 2015; 147: 1213-1218.
15. Teman NR, Haft JW, Napolitano LM. Optimal endovascular methods for placement of bicaval dual-lumen cannulae for venovenous extracorporeal membrane oxygenation. ASAIO J 2013; 59: 442-447.
16. Cardiac Assist I. Protek Duo. 2015. http: //www.cardiacassist.com/protekduo/. [Accessed 9 August 2015]
17. Annich GM, Meinhardt JP, Mowery KA, et al. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 2000; 28: 915-920.
18. Amoako KA, Montoya PJ, Major TC, et al. Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungs. J Biomed Mater Res A 2013; 101: 3511-3519.
19. Coughlin MA, Bartlett RH. Anticoagulation for extracorporeal life support: direct thrombin inhibitors and heparin. ASAIO J 2015; 61: 652-655.
20. Ogino MT, Chuo J, Short BL. ECMO administrative and training issues and sustaining quality. In: ECMO: extracorporeal support in critical care. Ann Arbor, Michigan: Extracorporeal Life Support Organization; 2012.
21. Hoganson DM, Gazit AZ, Boston US, et al. Paracorporeal lung assist devices as a bridge to recovery or lung transplantation in neonates and young children. J Thorac Cardiovasc Surg 2014; 147: 420-426.
22. Patil NP, Mohite PN, Reed A, et al. Modified technique using Novalung as bridge to transplant in pulmonary hypertension. Ann Thorac Surg 2015; 99: 719-721.
23. Schmid C, Philipp A, Hilker M, et al. Bridge to lung transplantation through a pulmonary artery to left atrial oxygenator circuit. Ann Thorac Surg 2008; 85: 1202-1205.
24. Iglesias M, Jungebluth P, Petit C, et al. Extracorporeal lung membrane provides better lung protection than conventional treatment for severe postpneumonectomy noncardiogenic acute respiratory distress syndrome. J Thorac Cardiovasc Surg 2008; 135: 1362-1371.